Nighttime systolic blood pressure a major factor of retinal vascular caliber changes in patients with newly diagnosed type 2 diabetes mellitus.

IF 3.2 3区 医学 Q2 PERIPHERAL VASCULAR DISEASE
Barbara Nikolaidou, Areti Triantafyllou, Panagiota Anyfanti, Eleni Gavriilaki, Antonios Lazaridis, Panagiotis Dolgyras, Maria Gavriilaki, Anastasia Stoimeni, Konstantinos Mastrogiannis, Christina Trakatelli, Michael Doumas, Eugenia Gkaliagkousi
{"title":"Nighttime systolic blood pressure a major factor of retinal vascular caliber changes in patients with newly diagnosed type 2 diabetes mellitus.","authors":"Barbara Nikolaidou, Areti Triantafyllou, Panagiota Anyfanti, Eleni Gavriilaki, Antonios Lazaridis, Panagiotis Dolgyras, Maria Gavriilaki, Anastasia Stoimeni, Konstantinos Mastrogiannis, Christina Trakatelli, Michael Doumas, Eugenia Gkaliagkousi","doi":"10.1093/ajh/hpaf004","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Changes in retinal vessel caliber are crucial for detecting early retinopathy, a significant cause of blindness in individuals with Diabetes Mellitus type 2 (T2DM). This study aims to evaluate the changes in retinal vessel caliber and identify factors associated with these changes in recently diagnosed T2DM patients.</p><p><strong>Methods: </strong>The study included newly diagnosed T2DM patients (within 6 months of diagnosis) who were free of antidiabetic treatment (except metformin) and matched individuals based on age and blood pressure (BP). Data collected included somatometric measurements, BP (office and 24-hour), hematological data, albuminuria (via 24-hour urine collections), ten-year atherosclerotic cardiovascular disease risk (ASCVD score), endothelial dysfunction (measured by Asymmetric Dimethylarginine, ADMA), retinal microvascular changes, assessed as central retinal arteriolar equivalent (CRAE), central retinal venular equivalent (CRVE), and arteriovenous ratio (AVR) using specialized software on non-mydriatic fundus photographs.</p><p><strong>Results: </strong>The study involved 87 T2DM patients and 90 controls, aged 57±11 years. Key findings include no significant differences in CRAE, CRVE, and AVR between T2DM patients and controls. Age (p=0.019) and nighttime systolic BP (SBP) (p=0.002) were independent predictors of AVR. CRAE was independently associated with nighttime SBP (p=0.048). CRVE was independently associated with age (p=0.016), dipping (p=0.002), and smoking (p=0.018). In normotensive subjects, AVR was significantly lower in T2DM patients (p=0.035).</p><p><strong>Conclusions: </strong>The study concludes that increased nighttime SBP is a more critical factor than hyperglycemia in affecting retinal vascular caliber changes in newly diagnosed T2DM patients. This highlights the importance of managing nocturnal hypertension to prevent retinal damage in this patient population.</p>","PeriodicalId":7578,"journal":{"name":"American Journal of Hypertension","volume":" ","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Hypertension","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ajh/hpaf004","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Changes in retinal vessel caliber are crucial for detecting early retinopathy, a significant cause of blindness in individuals with Diabetes Mellitus type 2 (T2DM). This study aims to evaluate the changes in retinal vessel caliber and identify factors associated with these changes in recently diagnosed T2DM patients.

Methods: The study included newly diagnosed T2DM patients (within 6 months of diagnosis) who were free of antidiabetic treatment (except metformin) and matched individuals based on age and blood pressure (BP). Data collected included somatometric measurements, BP (office and 24-hour), hematological data, albuminuria (via 24-hour urine collections), ten-year atherosclerotic cardiovascular disease risk (ASCVD score), endothelial dysfunction (measured by Asymmetric Dimethylarginine, ADMA), retinal microvascular changes, assessed as central retinal arteriolar equivalent (CRAE), central retinal venular equivalent (CRVE), and arteriovenous ratio (AVR) using specialized software on non-mydriatic fundus photographs.

Results: The study involved 87 T2DM patients and 90 controls, aged 57±11 years. Key findings include no significant differences in CRAE, CRVE, and AVR between T2DM patients and controls. Age (p=0.019) and nighttime systolic BP (SBP) (p=0.002) were independent predictors of AVR. CRAE was independently associated with nighttime SBP (p=0.048). CRVE was independently associated with age (p=0.016), dipping (p=0.002), and smoking (p=0.018). In normotensive subjects, AVR was significantly lower in T2DM patients (p=0.035).

Conclusions: The study concludes that increased nighttime SBP is a more critical factor than hyperglycemia in affecting retinal vascular caliber changes in newly diagnosed T2DM patients. This highlights the importance of managing nocturnal hypertension to prevent retinal damage in this patient population.

夜间收缩压是新诊断的2型糖尿病患者视网膜血管口径变化的主要因素。
背景:视网膜血管直径的变化对于发现早期视网膜病变是至关重要的,视网膜病变是2型糖尿病(T2DM)患者失明的重要原因。本研究旨在评估新近诊断的T2DM患者视网膜血管直径的变化,并确定与这些变化相关的因素。方法:研究纳入未接受降糖治疗(二甲双胍除外)的新诊断T2DM患者(诊断后6个月内)和根据年龄和血压(BP)匹配的个体。收集的数据包括体测、血压(办公室和24小时)、血清学数据、蛋白尿(通过24小时尿液收集)、10年动脉粥样硬化性心血管疾病风险(ASCVD评分)、内皮功能障碍(通过不对称二甲基精氨酸测量,ADMA)、视网膜微血管改变,评估为视网膜中央动脉当量(CRAE)、视网膜中央静脉当量(CRVE)、和动静脉比(AVR)使用专门的软件对非散瞳眼底照片。结果:T2DM患者87例,对照组90例,年龄57±11岁。主要发现包括T2DM患者和对照组之间CRAE、CRVE和AVR无显著差异。年龄(p=0.019)和夜间收缩压(SBP) (p=0.002)是AVR的独立预测因子。CRAE与夜间收缩压独立相关(p=0.048)。CRVE与年龄(p=0.016)、饮酒(p=0.002)、吸烟(p=0.018)独立相关。在正常血压的受试者中,T2DM患者的AVR显著降低(p=0.035)。结论:本研究表明,夜间收缩压升高是影响新诊断T2DM患者视网膜血管口径变化的一个比高血糖更关键的因素。这突出了管理夜间高血压的重要性,以防止视网膜损伤的患者群体。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
American Journal of Hypertension
American Journal of Hypertension 医学-外周血管病
CiteScore
6.90
自引率
6.20%
发文量
144
审稿时长
3-8 weeks
期刊介绍: The American Journal of Hypertension is a monthly, peer-reviewed journal that provides a forum for scientific inquiry of the highest standards in the field of hypertension and related cardiovascular disease. The journal publishes high-quality original research and review articles on basic sciences, molecular biology, clinical and experimental hypertension, cardiology, epidemiology, pediatric hypertension, endocrinology, neurophysiology, and nephrology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信